These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9180431)

  • 1. Iron management in ESRD and the role of the nephrology nurse.
    Robbins KC; Senger JM; Kerhulas S; Fishbane S
    ANNA J; 1997 Apr; 24(2):265-72; quiz 273-4. PubMed ID: 9180431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of anemia in chronic kidney disease (predialysis) patients: nephrology nursing implications.
    Wish JB; Weigel KA
    Nephrol Nurs J; 2001 Jun; 28(3):341-5. PubMed ID: 12143456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
    Ahluwalia N; Skikne BS; Savin V; Chonko A
    Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron management in renal failure patients--how do we achieve the best results?
    Kosch M; Schaefer RM
    EDTNA ERCA J; 2002; 28(4):182-4. PubMed ID: 12638935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of ferritin as a marker of anemia in end stage renal disease.
    Dennison HA
    ANNA J; 1999 Aug; 26(4):409-14; quiz 419-20. PubMed ID: 10838972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia of chronic renal failure: new treatment alternative.
    Seiler S
    CANNT J; 2000; 10(3):35-9, 43-8; quiz 40-2, 49-51. PubMed ID: 11799582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoetin alfa--focus on nutritional therapy. Case study of the anemic patient.
    College J
    ANNA J; 1996 Aug; 23(4):416-9. PubMed ID: 8900689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of early utilization of intravenous iron.
    Vogel S
    Nephrol Nurs J; 2000 Feb; 27(1):61-5. PubMed ID: 10852693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenges of using serum ferritin to guide i.v. iron treatment practices in patients on hemodialysis with anemia.
    Easom A
    Nephrol Nurs J; 2006; 33(5):543-51; quiz 552-3. PubMed ID: 17044438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era.
    Kalantar-Zadeh K; Höffken B; Wünsch H; Fink H; Kleiner M; Luft FC
    Am J Kidney Dis; 1995 Aug; 26(2):292-9. PubMed ID: 7645533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency in patients with renal failure.
    Nissenson AR; Strobos J
    Kidney Int Suppl; 1999 Mar; 69():S18-21. PubMed ID: 10084282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating traditional iron measures and exploring new options for patients on hemodialysis.
    Petroff S
    Nephrol Nurs J; 2005; 32(1):65-73; quiz 74-5. PubMed ID: 15787086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caring for the renal failure patient: optimizing iron therapy.
    Folkert VW; Javier AM; O'Mara NB
    Nephrol Nurs J; 2002 Dec; 29(6):586-93; quiz 594-5. PubMed ID: 12596608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing anemia using laboratory trend analysis. Case study of the anemic patient.
    Aiello J
    ANNA J; 1999 Aug; 26(4):430-3. PubMed ID: 10838975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety aspects of parenteral iron in patients with end-stage renal disease.
    Sunder-Plassmann G; Hörl WH
    Drug Saf; 1997 Oct; 17(4):241-50. PubMed ID: 9352960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintaining iron balance with total-dose infusion of intravenous iron dextran.
    Case G
    ANNA J; 1998 Feb; 25(1):65-8. PubMed ID: 9543911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of inflammation on nutrition, iron status, and erythropoietin responsiveness in ESRD patients.
    Bistrian BR; Carey LA
    Nephrol Nurs J; 2000 Dec; 27(6):616-22. PubMed ID: 16649343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.